Literature DB >> 20433927

Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile.

Amit Sundriyal1, April K Roberts, Roger Ling, Joanna McGlashan, Clifford C Shone, K Ravi Acharya.   

Abstract

Clostridium difficile infection (CDI) is a serious problem within the healthcare environment where the bacterium causes symptoms ranging from mild diarrhoea to life-threatening colitis. In addition to its principal virulence factors, Toxin A and Toxin B, some C. difficile strains produce a binary toxin (CDT) composed of two sub-units namely CDTa and CDTb that are produced and secreted from the cell as two separate polypeptides. Once in the gut these fragments have the potential to combine to form a potent cytotoxin whose role in the pathogenesis of CDI is presently unclear. Here, we describe expression and purification methods for recombinant CDTa and CDTb produced in Escherichia coli. We show that purified CDTa and CDTb can combine to form an active CDT which is cytotoxic to Vero cells. In addition, the purification processes described will allow milligram quantities of binary toxin fragments to be produced for further functional and structural studies. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433927     DOI: 10.1016/j.pep.2010.04.014

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  19 in total

Review 1.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

2.  Caspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins.

Authors:  Angela M Payne; Julie Zorman; Melanie Horton; Sheri Dubey; Jan ter Meulen; Kalpit A Vora
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

Review 3.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 4.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 5.  Clostridium difficile toxins: mediators of inflammation.

Authors:  Aimee Shen
Journal:  J Innate Immun       Date:  2012-01-10       Impact factor: 7.349

Review 6.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

Review 7.  The host immune response to Clostridium difficile infection.

Authors:  Katie Solomon
Journal:  Ther Adv Infect Dis       Date:  2013-02

8.  Development and optimization of a high-throughput assay to measure neutralizing antibodies against Clostridium difficile binary toxin.

Authors:  Jinfu Xie; Melanie Horton; Julie Zorman; Joseph M Antonello; Yuhua Zhang; Beth A Arnold; Susan Secore; Rachel Xoconostle; Matthew Miezeiewski; Su Wang; Colleen E Price; David Thiriot; Aaron Goerke; Marie-Pierre Gentile; Julie M Skinner; Jon H Heinrichs
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

9.  Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key.

Authors:  David B Stewart; Arthur Berg; John Hegarty
Journal:  J Gastrointest Surg       Date:  2012-10-20       Impact factor: 3.452

10.  Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism.

Authors:  Greice Krautz-Peterson; Yongrong Zhang; Kevin Chen; George A Oyler; Hanping Feng; Charles B Shoemaker
Journal:  J Toxicol       Date:  2011-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.